Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$113.79
-1.2%
$108.91
$88.96
$136.72
$2.12B0.81170,652 shs195,824 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$14.76
-2.0%
$9.78
$3.99
$15.34
$684.44M2.421.05 million shs2.83 million shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$4.83
-2.0%
$5.96
$4.64
$8.61
$1.92B1.221.63 million shs2.69 million shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$26.39
-1.6%
$29.09
$19.73
$47.32
$2.10B2.09916,003 shs1.68 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
-1.19%+0.88%+3.30%+26.67%-4.62%
LifeMD, Inc. stock logo
LFMD
LifeMD
-1.99%+18.46%+37.05%+163.57%+87.55%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.03%-8.17%-14.81%-29.49%-8.70%
Veracyte, Inc. stock logo
VCYT
Veracyte
-1.60%-0.19%-4.42%-17.06%+23.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.6384 of 5 stars
3.62.00.05.02.62.51.9
LifeMD, Inc. stock logo
LFMD
LifeMD
1.2922 of 5 stars
1.54.00.00.02.41.70.6
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.4227 of 5 stars
3.42.00.00.01.92.50.6
Veracyte, Inc. stock logo
VCYT
Veracyte
3.5201 of 5 stars
3.41.00.04.32.80.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
3.25
Buy$142.5725.29% Upside
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$12.00-18.70% Downside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.83
Moderate Buy$8.5075.98% Upside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.70
Moderate Buy$40.9054.98% Upside

Current Analyst Ratings Breakdown

Latest LFMD, ADUS, VCYT, and LFST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/20/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00
6/18/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $18.00
6/10/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$133.00
5/27/2025
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$8.50
5/8/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$49.00 ➝ $42.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$51.00 ➝ $41.00
4/30/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00
4/22/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
4/10/2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
4/9/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$45.00 ➝ $37.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.15B1.81$5.32 per share21.37$53.52 per share2.13
LifeMD, Inc. stock logo
LFMD
LifeMD
$212.45M3.16N/AN/A($0.09) per share-164.00
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.25B1.50$0.04 per share124.33$3.78 per share1.28
Veracyte, Inc. stock logo
VCYT
Veracyte
$445.76M4.64$1.02 per share25.87$15.17 per share1.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$73.60M$4.4325.6921.231.636.52%9.23%6.96%8/4/2025 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
-$18.88M-$0.34N/A123.00N/A-4.58%N/A-15.19%8/6/2025 (Estimated)
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-$57.44M-$0.10N/AN/AN/A-2.78%-2.47%-1.69%8/14/2025 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
$24.14M$0.4164.3736.65N/A7.13%6.14%5.60%8/5/2025 (Estimated)

Latest LFMD, ADUS, VCYT, and LFST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.04$0.01+$0.05$0.01$62.47 million$65.70 million
5/5/2025Q1 2025
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.33$1.42+$0.09$1.16$341.66 million$337.71 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.20
1.74
1.74
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
0.82
0.77
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.19
1.47
1.47
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
5.10
4.78

Institutional Ownership

CompanyInstitutional Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
95.35%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A

Insider Ownership

CompanyInsider Ownership
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.60%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.20%
Veracyte, Inc. stock logo
VCYT
Veracyte
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
49,70318.40 million17.55 millionOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23045.45 million37.09 millionOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
10,218388.88 million376.43 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
79078.32 million77.22 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Addus HomeCare stock logo

Addus HomeCare NASDAQ:ADUS

$113.79 -1.37 (-1.19%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$114.60 +0.81 (+0.72%)
As of 06/20/2025 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$14.76 -0.30 (-1.99%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$14.80 +0.04 (+0.30%)
As of 06/20/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$4.83 -0.10 (-2.03%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$4.93 +0.10 (+1.99%)
As of 06/20/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Veracyte stock logo

Veracyte NASDAQ:VCYT

$26.39 -0.43 (-1.60%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$27.06 +0.67 (+2.54%)
As of 06/20/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.